When was ThermoGenesis founded?

ThermoGenesis was founded in 1986 and raised its 1st funding round 23 years after it was founded.

Where is ThermoGenesis located?

ThermoGenesis is headquartered in Rancho Cordova, United States. It is registered at Rancho Cordova, California.

How many employees does ThermoGenesis have?

As of May 31, 2026, the latest employee count at ThermoGenesis is 58.

Is ThermoGenesis a funded company?

ThermoGenesis is a funded company, having raised an undisclosed amount across 5 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 21, 2009.

When was the latest funding round of ThermoGenesis?

ThermoGenesis' latest funding was a $***** Post IPO round on Mar 22, 2023, with participation from 0 investor.

What is the annual revenue of ThermoGenesis?

Annual revenue of ThermoGenesis is $18M as on Jun 30, 2013.

Where does ThermoGenesis rank among its competitors?

ThermoGenesis ranks 8th amongst 26 active competitors, of which 10 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Cellares, which secured $257M in Jan, 2026.

Who are the top competitors of ThermoGenesis?

ThermoGenesis' top competitors include Oribiotech, Cellares and Multiply Labs. Among them, Cellares secured the most recent funding round in January, 2026.

ThermoGenesis - 2026 Company Profile, Funding, Competitors & Financials

ThermoGenesis is a public company based in Rancho Cordova (United States), founded in 1986. It operates as a Provider of automated technologies for cell-based therapeutics and bio-processing. ThermoGenesis has raised an undisclosed amount in funding. The company has 26 active competitors, including 10 funded and 1 that has exited. Its top competitors include companies like Oribiotech, Cellares and Multiply Labs.

Company Details

ThermoGenesis is developing automated technologies for cell-based therapeutics and bio-processing. It offers automated clinical biobanking, point-of-care applications for cell-based therapeutics, and automation for immuno-oncology. It offers AXP BioArchive which provides automated isolation, collection and storage of cord blood stem cells. Another product, MXP allows automated processing of autologous peripheral or bone marrow-derived stem cells. CXP + BioArchive is the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology. The company operates as a wholly owned subsidiary of Cesca Therapeutics.

Website: thermogenesis.com
Social
Email ID: *****@thermogenesis.com
Phone Number: +1 **********
Part Of
Registered Address: Rancho Cordova, California

Key Metrics

Founded Year

1986

Location

Rancho Cordova, United States

Stage

Public

Latest Funding Round

Post IPO, Mar 22, 2023, $*****

Investors

Bay City Capital & 1 more

Ranked

8^th among 26 active competitors

Annual Revenue

$18M as on Jun 30, 2013

Employee Count

58 as on May 31, 2026

Similar Companies

Oribiotech & 25 more

Exit Details

Public

View ThermoGenesis' full profile

ThermoGenesis is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Thermogenesis Corp. CIN: 943018487 , United States, Active	Dec 31, 1999	-	23 (As on Dec 31, 2024)	-
CESCA THERAPEUTICS INC. CIN: 811212 , United States, Active	Dec 25, 2018	$9.44M (As on Dec 31, 2023)	41 (As on Dec 31, 2022)	-
Thermogenesis Corp CIN: 811212 , United States, Active		$18M (As on Jun 30, 2013)	-	-

ThermoGenesis got listed on Jun 17, 2024.

Click here to take a look at ThermoGenesis's IPO in detail

ThermoGenesis has raised funding over 5 rounds. Its first funding round was on May 21, 2009. ThermoGenesis has 2 institutional investors.

Here is the list of recent funding rounds of ThermoGenesis:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 22, 2023	5390022	Post IPO	1254730	3381009	5928325	8017302
Sep 08, 2021	8694193	Grant (prize money)	4747233	1222824	7833150	HHS
Mar 26, 2018	5800512	Post IPO	5718679	5774327	5584607	1394118

Access funding benchmarks and valuations. Sign up today!

View details of ThermoGenesis's funding rounds and investors

ThermoGenesis' employee count trend

ThermoGenesis has 58 employees as of May 26. Here is ThermoGenesis's employee count trend over the years:

Uncover ThermoGenesis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ThermoGenesis include Oribiotech, Cellares and Multiply Labs. Here is the list of Top 10 competitors of ThermoGenesis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Oribiotech 2015, London (United Kingdom), Series B	Biotech company focused on advancing cell and gene therapy manufacturing through innovative automation tool	$281M	Novalis LifeSciences, Northpond Ventures ... & 17 others	66/100
2nd	Cellares 2019, San Francisco (United States), Series D	Manufacturer of a medical device for cell-based therapy	$612M	Eclipse, BlackRock & 16 others	64/100
3rd	Multiply Labs 2016, San Francisco (United States), Series A	Manufacturer of precision medicines through innovative robotic technology	$41.3M	Zillionize, Casdin Capital & 22 others	64/100
4th	Astraveus 2016, Paris (France), Seed	Provider of a device for autologous cell and gene therapies	$18M	AdBio partners, Bpifrance & 5 others	55/100
5th	Cellular Origins 2022, Melbourn (United Kingdom), Series A	Provider of automated manufacturing solution for cell and gene therapy	$40M	Johnson & Johnson, The Technology Partnership ... & 3 others	55/100
6th	Celltrio 2018, Fremont (United States), Series B	Developer of automated biobanking and cell culture systems	$15M	Premier Partners	48/100
7th	Unicorn Biotechnologies 2020, Sheffield (United Kingdom), Seed	Developer of bioreactors for cell-based manufacturing	$3.2M	Acequia Capital, HAX & 9 others	43/100
8th	ThermoGenesis 1986, Rancho Cordova (United States), Public	Provider of automated technologies for cell-based therapeutics and bio-processing	-	Bay City Capital, HHS	40/100
9th	Shenzhen Shenyan Biotechnology 2014, Shenzhen (China), Series B	Developer of automated cell processing system	$56.7M	Eight Roads Ventures, Tasly & 3 others	40/100
10th	Cell X Technologies 2017, Cleveland (United States), Funding Raised	Developer of regenerative medicine to measure and manage human cell sources	-	Denniston Family Office, Innovation Works ... & 2 others	35/100